Cohen H, Scott SD, Mackie IJ, et al. The development of hypoprothrombinaemia following antibiotic therapy in malnourished patients with low serum vitamin K
1
levels.
Br J Haematol
68: 63–66, 1988.
Conly J and Stein K. Reduction of vitamin K
2
concentrations in human liver associated with the use of broad spectrum antimicrobials.
Clin Invest Med
17: 531–539, 1994.
Shearer MJ, Bechtold H, Andrassy K, et al. Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status.
J Clin Pharmacol
28: 88–95, 1988.
Goss TF, Walawander CA, Grasela TH, et al. Prospective evaluation of risk factors for antibiotic-associated bleeding in critically ill patients.
Pharmacotherapy
12: 283–291, 1992.
Fuller R. Probiotics in human medicine.
Gut
32: 439–442, 1991.
Elmer GW, Surawicz CM, and McFarland LV. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections.
JAMA
275: 870–876, 1996.
Catanzaro JA and Green L. Microbial ecology and probiotics in human medicine (Part II).
Alt Med Rev
2: 296–305, 1997.
Gorbach SL. Lactic acid bacteria and human health.
Ann Med
22: 37–41, 1990.
Gotz V, Romankiewicz JA, Moss J, and Murray HW. Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation.
Am J Hosp Pharm
36: 754–757, 1979.
Colombel JF, Cortot A, Neut C, et al. Yoghurt with
Bifidobacterium longum
reduces erythromycin-induced gastrointestinal effects.
Lancet.
1987;2:43.
Vanderhoof JA, Whitney DB, Antonson DL, et al. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children.
J Pediatr. 1999;135:564–568.
Tankanow RM, Ross MB, Ertel IJ, et al. A double-blind, placebo-controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhea.
DICP. 1990;24:382–384.
Surawicz CM, Elmer GW, Speelman P, et al. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study.
Gastroenterology. 1989;96:981–988.
McFarland LV, Surawicz CM, Greenberg RN, et al. Prevention of Beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo.
Am J Gastroenterol. 1995;90:439–448.
Arvola T, Laiho K, Torkkeli S, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study.
Pediatrics. 1999;104:e64.
Siitonen S, Vapaatalo H, Salminen S, et al. Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea.
Ann Med. 1990;22:57–59.
Wullt M, Hagslatt ML, Odenholt I. Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial.
Scand J Infect Dis. 2003;35(6-7):365-7.
Beniwal RS, Arena VC, Thomas L, et al. A randomized trial of yogurt for prevention of antibiotic-associated diarrhea.
Dig Dis Sci. 2003;48:2077-82.
Correa NB, Peret Filho LA, Penna FJ et al. A Randomized Formula Controlled Trial of Bifidobacterium lactis and Streptococcus thermophilus for Prevention of Antibiotic-Associated Diarrhea in Infants.
J Clin Gastroenterol. 2005;39:385-389.
Kotowska M, Albrecht P, Szajewska H et al. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial.
Aliment Pharmacol Ther. 2005;21:583-90.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.